.jpg)
STAT+: Burst PIPEs? So-so returns for biotech’s once-buzzy financing vehicle
PIPEs were once the buzziest financing vehicle in biotech. Here's a look at how they've performed.
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
This is the one-year anniversary edition of the Biotech Scorecard newsletter!
I have poured my heart and soul into this endeavor. It’s been immensely gratifying, and I’m deeply grateful to all of you for the attention you’ve given it over the past 12 months.
